ORANGE COUNTY, CALIF. (January 10, 2024) – Beckman
Coulter, Inc. Particle Characterization announces a collaboration
agreement with Fort Lauderdale, Fla.-based ImmunoSite Technologies,
in which Beckman Coulter will refer customers seeking particle
characterization services to ImmunoSite and ImmunoSite will perform
those services using Beckman Coulter particle characterization
instrumentation.
"This agreement allows us to address the growing need for Good
Laboratory Practice contract lab services from our pharmaceutical
customers, while allowing our in-house lab to continue the
development of novel applications and our technical database," said
Tony Boova, group manager at Beckman Coulter.
"ImmunoSite’s GLP status was particularly important, as it
addresses customer requirements for regulatory compliance and
auditing."
As part of the collaboration, Beckman Coulter offers customers
technological training, applications support and expert data
analysis, while ImmunoSite offers additional chemical and
biological analytical services and the ability to analyze large
numbers of samples.
"The collaboration allows the particle characterization team to
expand the range of services offered to customers," said Elsa
Burgess, director of commercial operations with Beckman
Coulter. "We’re happy to be working with a company that
has ImmunoSite’s reputation for excellence in pharmaceutical
characterization."
Wade Bolton, CEO of ImmunoSite said, "Having long admired
Beckman Coulter’s expertise in particle characterization,
we’re excited about the abilities of their instruments to
help us solve our customers’ complex problems. Particle
characterization testing will be an important adjunct to our
current pharma services in immune monitoring and
surveillance."
About Beckman Coulter Particle Characterization
The Particle Characterization Business Center is based in
Miami, Florida. The group develops, manufactures and markets
products that are used to study, analyze and quantify particles of
any type. The group serves customers as diverse as cell
biologists and cement manufacturers. Serving particle
customers since 1960, the group specializes in the Coulter
Principle, laser diffraction, dynamic light scattering, zeta
potential and BET analysis to understand all aspects of particulate
samples. For more information, visit www.coultercounter.com.
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify, automate
and innovate complex biomedical tests. This year marks the
company's 75th anniversary of advancing healthcare. More than
200,000 Beckman Coulter systems operate in laboratories around the
world, supplying critical information for improving patient health
and reducing the cost of care. Recurring revenue, consisting of
consumable supplies (including reagent test kits), service and
operating-type lease payments, represents about 80 percent of the
company's 2009 revenue of $3.3 billion. For more information, visit
www.beckmancoulter.com or
www.beckmancoulter.com/75years.
Beckman Coulter and the stylized logo are registered trademarks
of Beckman Coulter, Inc.
SOURCE